BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35175546)

  • 41. Racial and ethnic disparities in survival of children with brain and central nervous tumors in the United States.
    Haizel-Cobbina J; Spector LG; Moertel C; Parsons HM
    Pediatr Blood Cancer; 2021 Jan; 68(1):e28738. PubMed ID: 32970937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Central nervous system (CNS) tumors in the first six months of life: the Children's Hospital Los Angeles experience, 1979-2005.
    Serowka K; Chiu Y; Gonzalez I; Gilles F; McComb G; Krieger M; Dhall G; Britt B; Ji L; Sposto R; Finlay JL
    Pediatr Hematol Oncol; 2010 Mar; 27(2):90-102. PubMed ID: 20201690
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of survival between the UK and US after surgery for most common pediatric CNS tumors.
    Mathew RK; O'Kane R; Parslow R; Stiller C; Kenny T; Picton S; Chumas PD
    Neuro Oncol; 2014 Aug; 16(8):1137-45. PubMed ID: 24799454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors.
    Han YP; Ma CK; Wang SQ; Enomoto A; Zhao Y; Takahashi M; Ma J
    J Neurooncol; 2014 Sep; 119(2):343-51. PubMed ID: 24879375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiology of central nervous system tumors in children and young adults (0-29 years), Yorkshire, United Kingdom.
    Feltbower RG; Picton S; Bridges LR; Crooks DA; Glaser AW; McKinney PA
    Pediatr Hematol Oncol; 2004; 21(7):647-60. PubMed ID: 15626021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pediatric brain tumors in a low/middle income country: does it differ from that in developed world?
    Ezzat S; Kamal M; El-Khateeb N; El-Beltagy M; Taha H; Refaat A; Awad M; Abouelnaga S; Zaghloul MS
    J Neurooncol; 2016 Jan; 126(2):371-6. PubMed ID: 26514358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PD-1/PD-L1 and immune-related gene expression pattern in pediatric malignant brain tumors: clinical correlation with survival data in Korean population.
    Hwang K; Koh EJ; Choi EJ; Kang TH; Han JH; Choe G; Park SH; Yearley JH; Annamalai L; Blumenschein W; Sathe M; McClanahan T; Jung H; Wang KC; Kim SK; Kim CY
    J Neurooncol; 2018 Sep; 139(2):281-291. PubMed ID: 29730815
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of the treatment approach and survival outcomes in a modern cohort of patients with atypical teratoid rhabdoid tumors using the National Cancer Database.
    Fischer-Valuck BW; Chen I; Srivastava AJ; Floberg JM; Rao YJ; King AA; Shinohara ET; Perkins SM
    Cancer; 2017 Feb; 123(4):682-687. PubMed ID: 27861763
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011.
    Ostrom QT; de Blank PM; Kruchko C; Petersen CM; Liao P; Finlay JL; Stearns DS; Wolff JE; Wolinsky Y; Letterio JJ; Barnholtz-Sloan JS
    Neuro Oncol; 2015 Jan; 16 Suppl 10(Suppl 10):x1-x36. PubMed ID: 25542864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical predictors of survival for patients with atypical teratoid/rhabdoid tumors.
    Bachu VS; Shah P; Jimenez AE; Khalafallah AM; Tailor J; Mukherjee D; Cohen AR
    Childs Nerv Syst; 2022 Jul; 38(7):1297-1306. PubMed ID: 35362829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multimodality treatment for Central Nervous System Germ Cell Tumors: Disease spectrum and management strategies - A tertiary care center experience from India.
    Kumar N; Madan R; Dracham CB; Khosla D; Das N; Dey T; Elangovan A; Tripathi M; Gupta K; Ahuja CK; Kapoor R
    Clin Neurol Neurosurg; 2021 Mar; 202():106481. PubMed ID: 33508649
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intracranial Tumors in the First Year of Life.
    Salomão JFM; Protzenko T
    Adv Tech Stand Neurosurg; 2023; 46():23-52. PubMed ID: 37318568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relapse patterns in pediatric embryonal central nervous system tumors.
    Perreault S; Lober RM; Carret AS; Zhang G; Hershon L; Décarie JC; Yeom K; Vogel H; Fisher PG; Partap S
    J Neurooncol; 2013 Nov; 115(2):209-15. PubMed ID: 23921420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial.
    Grundy RG; Wilne SH; Robinson KJ; Ironside JW; Cox T; Chong WK; Michalski A; Campbell RH; Bailey CC; Thorp N; Pizer B; Punt J; Walker DA; Ellison DW; Machin D;
    Eur J Cancer; 2010 Jan; 46(1):120-33. PubMed ID: 19818598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors.
    Leary SES; Onar-Thomas A; Fangusaro J; Gottardo NG; Cohen K; Smith A; Huang A; Haas-Kogan D; Fouladi M;
    Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30600. PubMed ID: 37534382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survival of children with brain tumors: SEER Program, 1973-1980.
    Duffner PK; Cohen ME; Myers MH; Heise HW
    Neurology; 1986 May; 36(5):597-601. PubMed ID: 3703257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in survival over time for primary brain and other CNS tumors in the United States, 2004-2017.
    Cioffi G; Waite KA; Edelson JL; Kruchko C; Ostrom QT; Barnholtz-Sloan JS
    J Neurooncol; 2022 Oct; 160(1):209-219. PubMed ID: 36198894
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recurrence Patterns and Surveillance Imaging in Pediatric Brain Tumor Survivors.
    Cacciotti C; Lenzen A; Self C; Pillay-Smiley N
    J Pediatr Hematol Oncol; 2024 Apr; 46(3):e227-e232. PubMed ID: 38447113
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience.
    Zaky W; Dhall G; Ji L; Haley K; Allen J; Atlas M; Bertolone S; Cornelius A; Gardner S; Patel R; Pradhan K; Shen V; Thompson S; Torkildson J; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2014 Jan; 61(1):95-101. PubMed ID: 23934933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical Features and Survival Outcomes in Children and Adolescents With Malignant Mediastinal Germ Cell Tumors Based on Surveillance, Epidemiology, and End Results Database Analysis.
    Wu P; Yang Y; Yu Z; Zhao L; Feng S
    J Surg Res; 2023 Aug; 288():362-371. PubMed ID: 37062232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.